Not available
Quote | Livzon Pharmaceutical Group Inc (OTCMKTS:LVZPF)
Last: | $3.20 |
---|---|
Change Percent: | 0.0% |
Open: | $3.2 |
Close: | $3.20 |
High: | $3.2 |
Low: | $3.2 |
Volume: | 108 |
Last Trade Date Time: | 04/15/2024 03:00:00 am |
News | Livzon Pharmaceutical Group Inc (OTCMKTS:LVZPF)
2023-03-20 01:10:00 ET Summary Livzon entered a $127.5 million agreement for China rights to a gastroesophageal reflux disease (GERD) therapy from Onconic Therapeutics of Korea. Gracell Biotech announced in a press release that it had entered an unusual, non-exclusive global deal ...
Deals and Financings Ocumension [HK:1477], a Shanghai ophthalmic pharma, completed a $184 million Hong Kong IPO and climbed 152% in its first trading session, giving the company a valuation of about $2.5 billion (see story ). Founded in 2017, Ocumension was incubated by 6 Dimensions Capital...
Message Board Posts | Livzon Pharmaceutical Group Inc (OTCMKTS:LVZPF)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Livzon Pharmaceutical Group Inc Company Name:
LVZPF Stock Symbol:
OTCMKTS Market:
New York City, NY: April 06, 2020 – Published via (Wired Release) – Recent Research and Future Market Potential of Cephradine Market in Global Industry: 2020 Research and New Innovations in Chemicals and Materials Sector. The prime objective of the report is to offer updates and ...